Abstract
Hyperglycaemia and diabetes are frequent complications of anti‐cancer therapy in people with or without diagnosed diabetes.Steve Chaplin here reports on recently produced guidelines that provide advice for the oncology and haemato‐oncology multidisciplinary teams but, in addition to information about diabetes with which those specialists may not be familiar, they include a lot of detail about cancer therapy that endocrinologists may find useful.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.